Drug Shortage Report for SUPREFACT

Last updated on 2019-06-04 History
Report ID 83015
Drug Identification Number 02225158
Brand name SUPREFACT
Common or Proper name Suprefact
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUSERELIN
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration NASAL
Packaging size 2
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-05-10
Actual start date
Estimated end date 2019-06-28
Actual end date 2019-06-03
Shortage status Resolved
Updated date 2019-06-04
Company comments Manufacturing Delay. The anticipated availability dates represent estimated availabilities at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2019-06-04 English Compare
v9 2019-06-03 French Compare
v8 2019-06-03 English Compare
v7 2019-06-03 French Compare
v6 2019-06-03 English Compare
v5 2019-06-03 French Compare
v4 2019-06-03 English Compare
v3 2019-05-11 English Compare
v2 2019-05-02 French Compare
v1 2019-05-02 English Compare

Showing 1 to 10 of 10